RESMED INC — Director's Dealing 2019

Mar 4, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2019-03-01

Reporting Person: Hollingshead James (President, Sleep Business)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-03-01	ResMed Common Stock	M	800	$58.24	Acquired	82057	Direct
2019-03-01	ResMed Common Stock	S	800	$102.80	Disposed	81257	Direct
2019-03-01	ResMed Common Stock	S	800	$102.80	Disposed	80457	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-03-01	ResMed Common Stock Options	$58.24	M	800	Disposed	2022-11-19	ResMed Commmon Stock (800)	Direct

Footnotes

F1: The transaction was conducted under a Rule 10b5-1 plan.

F2: Represents date options first became exercisable. Options vest 1/3 per year.